How should I manage a 17‑year‑old female with low ferritin (~18 µg/L), elevated C‑reactive protein (15.6 mg/L) who is currently taking folic acid and whose recent ferritin was 23.7 µg/L?

Management of a 17-Year-Old Female with Low Ferritin and Elevated CRP

Start oral iron supplementation immediately with ferrous sulfate 325 mg daily (providing 65 mg elemental iron) while simultaneously investigating the underlying cause of iron deficiency, particularly heavy menstrual bleeding and dietary inadequacy. 1, 2

Diagnostic Interpretation

Confirming Iron Deficiency in the Context of Inflammation

• Your patient's ferritin of 18–23.7 µg/L confirms depleted iron stores even with the elevated CRP of 15.6 mg/L. 1, 3 While inflammation can falsely elevate ferritin, a level below 30 µg/L still indicates true iron deficiency. 1, 3

• In the presence of inflammation (CRP 15.6 mg/L), ferritin up to 100 µg/L may still be compatible with iron deficiency. 3 Your patient's ferritin of 18–23.7 µg/L is well below this threshold, confirming absolute iron deficiency despite the inflammatory state. 1

• The optimal ferritin cut-off for diagnosing iron deficiency in adolescent females is approximately 20–25 µg/L based on physiologic studies. 4 Your patient's values fall at or just above this threshold, indicating she is iron deficient or at best has marginal iron stores.

• Calculate transferrin saturation (serum iron ÷ total iron-binding capacity × 100) if available; a value <16–20% would further confirm iron-deficient erythropoiesis. 1, 3

Understanding the Folic Acid Context

• Folic acid supplementation alone does not address iron deficiency and may have obscured the diagnosis if anemia was present. 5 The FDA label warns that folic acid in doses above 0.1 mg daily can mask anemia by improving hemoglobin while leaving iron stores depleted. 5

• The increase in ferritin from 18 to 23.7 µg/L while on folic acid alone is minimal and does not represent adequate iron repletion. 1 This small rise likely reflects either measurement variability or the inflammatory state (elevated CRP), not true improvement in iron stores.

Immediate Treatment Protocol

Iron Supplementation Regimen

• Prescribe ferrous sulfate 325 mg once daily, taken on an empty stomach with 500 mg vitamin C (ascorbic acid) to enhance absorption. 2 This provides 65 mg of elemental iron per dose. 1, 2

• Continue treatment for at least 3–6 months to replenish iron stores, with a target ferritin >50–100 µg/L. 3, 2 Do not stop therapy once hemoglobin normalizes, as stores must be fully repleted to prevent recurrence. 3

• Expect a hemoglobin rise of ≥10 g/L within 2 weeks if iron deficiency is the primary cause of any anemia. 1, 3 This therapeutic response confirms the diagnosis even when initial iron studies are equivocal. 1

Folic Acid Continuation

• Continue folic acid 0.4 mg daily as maintenance for adolescents ≥4 years of age. 5 However, ensure that iron deficiency is being adequately treated with iron supplementation, as folic acid alone will not correct iron deficiency. 5

• Do not use folic acid doses >1 mg daily, as excess is excreted unchanged in urine and provides no additional hematologic benefit. 5

Investigation of Underlying Cause

Primary Etiologies in Adolescent Females

• Heavy menstrual bleeding is the most common cause of iron deficiency in adolescent females and must be assessed through detailed menstrual history (cycle length, duration, pad/tampon use per day, presence of clots). 1 However, this alone should not preclude further evaluation if anemia is severe or other symptoms are present. 1

• Dietary inadequacy, particularly vegetarian or restrictive eating patterns, is a recognized risk factor for iron deficiency in adolescents. 1, 3 Obtain a detailed dietary history assessing intake of heme iron (meat, poultry, fish) and non-heme iron sources. 1

• The elevated CRP of 15.6 mg/L indicates an inflammatory process that requires investigation. 3 Common causes include chronic infection, inflammatory bowel disease, or autoimmune conditions. 1

Screening for Malabsorption

• Screen for celiac disease with tissue transglutaminase IgA antibody, as celiac disease accounts for 2–5% of iron deficiency cases and may present with isolated anemia. 1, 2 This is particularly important given the elevated CRP, which may reflect subclinical inflammation from undiagnosed celiac disease. 1

• Test for Helicobacter pylori, as chronic infection can cause occult gastrointestinal blood loss and impair iron absorption. 2 This is a non-invasive screening test that should be performed in adolescents with unexplained iron deficiency. 2

When to Consider Gastrointestinal Evaluation

• Bidirectional endoscopy (upper endoscopy with duodenal biopsies and colonoscopy) is not routinely indicated in adolescent females unless menstrual and dietary causes have been excluded, anemia is severe, or gastrointestinal symptoms are present. 1, 2 The priority in this age group is to assess menstrual losses and dietary intake first. 1

Monitoring and Follow-Up

Laboratory Reassessment

• Recheck hemoglobin after 2–4 weeks of iron therapy; an increase of ≥10 g/L confirms iron-deficient erythropoiesis. 1, 3 If hemoglobin does not rise appropriately, consider non-compliance, ongoing blood loss, malabsorption, or rare genetic disorders. 1, 3

• Measure ferritin after 3 months of treatment to assess iron store repletion; the goal is ferritin >50–100 µg/L. 3, 2 Continue iron supplementation until this target is achieved. 3, 2

• Repeat CRP at follow-up to determine if the inflammatory state has resolved or requires further investigation. 3 Persistent elevation warrants evaluation for chronic inflammatory conditions. 3

Adjusting Therapy

• If oral iron is not tolerated due to gastrointestinal side effects (nausea, constipation, abdominal pain), try alternative formulations such as ferrous gluconate or ferrous fumarate. 1, 3 Taking iron with food may reduce side effects but also decreases absorption. 2

• Consider intravenous iron if there is documented malabsorption (e.g., celiac disease), no response after 4–6 weeks of adequate oral therapy despite good compliance, or ongoing blood loss exceeding absorption capacity. 3, 2 Expected hemoglobin increase is ≥2 g/dL within 4 weeks of IV iron. 3

Critical Pitfalls to Avoid

• Do not attribute iron deficiency solely to dietary insufficiency without excluding pathologic causes, especially if the inflammatory marker (CRP) remains elevated. 1 Chronic inflammation suggests an underlying condition that requires diagnosis and treatment. 1, 3

• Do not rely on ferritin alone when inflammation is present; the elevated CRP means ferritin may underestimate the severity of iron deficiency. 1, 3 A ferritin of 18–23.7 µg/L in the setting of CRP 15.6 mg/L likely reflects more severe depletion than the number suggests. 3

• Do not stop iron supplementation once hemoglobin normalizes; continue for 3–6 months to fully replenish iron stores and prevent recurrence. 3, 2 Premature discontinuation is a common cause of relapse. 3

• Do not overlook combined micronutrient deficiencies; iron deficiency can coexist with vitamin B12 or folate deficiency. 3 If red cell distribution width (RDW) is elevated or if macrocytic cells are present on blood smear, check B12 and folate levels. 3

• Do not delay iron supplementation while pursuing diagnostic workup; start treatment immediately and investigate concurrently. 1, 2 Early treatment prevents progression of iron deficiency and improves outcomes. 1, 2